Changes in Radiosensitivity to Gamma-Rays of Lymphocytes from Hyperthyroid Patients Treated with I-131

Int J Mol Sci. 2022 Sep 5;23(17):10156. doi: 10.3390/ijms231710156.

Abstract

This study investigated the peripheral blood lymphocytes (PBL) response to a dose of γ-rays in patients treated with radioiodine (I-131) for hyperthyroidism vs. healthy controls, to gain information about the individual lymphocytes' radio-sensitivity. Blood samples were taken from 18 patients and 10 healthy donors. Phosphorylated histone variant H2AX (γ-H2AX) and micronuclei (MN) induction were used to determine the change in PBL radio-sensitivity and the correlations between the two types of damage. The two assays showed large inter-individual variability in PBL background damage and in radio-sensitivity (patients vs. healthy donors). In particular, they showed an increased radio-sensitivity in 36% and 33% of patients, decrease in 36% and 44%, respectively. There was a scarce correlation between the two assays and no dependence on age or gender. A significant association was found between high radio-sensitivity conditions and induced hypothyroidism. PBL radio-sensitivity in the patient group was not significantly affected by treatment with I-131, whereas there were significant changes inter-individually. The association found between clinical response and PBL radio-sensitivity suggests that the latter could be used in view of the development of personalized treatments.

Keywords: H2AX histone phosphorylation; I-131 therapy; micronucleus tests; peripheral blood lymphocytes; radio-sensitivity.

MeSH terms

  • Dose-Response Relationship, Radiation
  • Humans
  • Hyperthyroidism* / radiotherapy
  • Iodine Radioisotopes* / therapeutic use
  • Lymphocytes
  • Micronucleus Tests
  • Radiation Tolerance

Substances

  • Iodine Radioisotopes
  • Iodine-131

Grants and funding

This research received no external funding.